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Executive summary 
Background 
Intermittent energy restriction encompasses dietary approaches including intermittent fasting, 
alternate day fasting, and fasting for two days per week. Despite the recent popularity of 
intermittent energy restriction and associated weight loss claims, the supporting evidence base 
is limited.  
Objective 
To examine the effectiveness of intermittent energy restriction in the treatment for overweight 
and obesity in adults, when compared to usual care treatment or no treatment. 
Inclusion criteria 
Types of participants 
This review included overweight or obese (BMI ≥ 25 kg/m2) adults (≥ 18 years).  
Types of intervention(s) / phenomena of interest 
Intermittent energy restriction was defined as consumption of ≤ 800 kcal on at least one day, 
but no more than six days per week. Intermittent energy restriction interventions were compared 
to no treatment (ad libitum diet) or usual care (continuous energy restriction ~25% of 
recommended energy intake). Included Interventions had a minimum duration of 12 weeks from 
baseline to post outcome measurements. 
Types of studies 
Randomized and pseudo-randomized controlled trials. 
Types of outcomes 
The primary outcome of this review was change in body weight. Secondary outcomes included: 
1. Anthropometric outcomes (change in BMI; waist circumference; fat mass; fat free mass); 2. 
Cardio-metabolic outcomes (change in blood glucose and insulin, lipoprotein profiles and blood 
pressure; 3. Lifestyle outcomes: Diet, physical activity, quality of life and adverse events.  
Search strategy 
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A systematic search was conducted from database inception to November 2015. The following 
electronic databases were searched: MEDLINE; Embase; CINAHL; Cochrane library; 
Clinicaltrials.gov; ISRCTN registry; and anzctr.org.au for English language published studies, 
protocols, and trials.  
Methodological quality 
Two independent reviewers evaluated the methodological quality of included studies using the 
standardized critical appraisal instruments from the Joanna Briggs Institute. 
Data extraction 
Data were extracted from papers included in the review by two independent reviewers using the 
standardized data extraction tool from the Joanna Briggs Institute.  
Data synthesis 
Effect sizes were expressed as weighted mean differences and their 95% confidence intervals 
were calculated for meta-analyses. 
Results 
Six studies were included in this review. The intermittent energy restriction regimens varied 
across studies and included alternate day fasting, fasting for two days, and up to four days per 
week. The duration of studies ranged from three to 12 months. Four studies included continuous 
energy restriction as a comparator intervention and two studies included a no treatment control 
intervention. Meta-analyses showed that intermittent energy restriction was more effective than 
no treatment for weight loss (-4.14 kg; 95% CI -6.30 kg to -1.99 kg; p ≤ 0.001). Although, both 
treatment interventions achieved similar changes in body weight (Approximately 7 kg), the 
pooled estimate for studies that investigated the effect of intermittent energy restriction in 
comparison to continuous energy restriction revealed that no significant difference in weight 
loss (-1.03 kg; 95% CI -2.46 kg to 0.40 kg; p = 0.156).  
Conclusions 
Intermittent energy restriction may be an effective strategy for the treatment of overweight and 
obesity. Intermittent energy restriction was comparable to continuous energy restriction for short 
term weight loss in overweight and obese adults.  
Keywords 
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Background  
The management of overweight and obesity is considered a major public health priority internationally. 
Prevalence estimates of overweight and obesity reported by the World Health Organization in 2014 
showed that 39% (1.9 million) of adults aged 18 and over, were overweight, and of these 13% (600 
million) were obese.1 In adults there is evidence to support a persistent involuntary increase in body 
weight of between 0.24-0.45 kg per year in women and 0.25-0.58 kg per year in men,2,3 with even 
greater weight changes observed in younger adults (>2kg annually).3 Excess weight gain in adulthood 
has a negative impact on health and is associated with an increased risk of developing a number of 
chronic diseases including type II diabetes, cardiovascular disease, muscular skeletal disorders and 
some cancers.4,5 
The burgeoning obesity epidemic and its associated health conditions not only have an adverse impact 
on the individual but are also an increasing financial burden to society. In the UK, the cost of treatment 
of obesity related conditions to the National Health Service is estimated to be £6.1 billion per year.6 
Medical expenditure in the USA  has shown to be even greater with associated costs at $147 billion.7 
Furthermore, if trends in obesity continue to increase it is predicted that by 2050, 50% of the population 
in the UK could be obese and the total costs in managing obesity could escalate to £50 billion per year.8 
Therefore, effective approaches to the management of obesity are essential internationally.  
Weight management approaches in the treatment of obesity include a wide range of lifestyle 
interventions (including dietary, physical activity and psychological elements) to change unhealthy 
behaviours, encourage weight loss, and prevent chronic weight gain. However, many approaches only 
achieve small changes in body weight which are insufficient to have a clinical impact on health.9 
Furthermore, there are a number of diet and weight management books published, with book sales 
sufficient to reach the best sellers list, however, many of these lack comprehensive evaluation and 
robust evidence to support their effectiveness.10 Therefore, it is vitally important that new approaches 
to weight management are investigated for their potential efficacy in order to provide evidence based 
approaches to the treatment of obesity.  
Intermittent fasting is currently a popular approach considered for weight management which has 
received significant media attention and hence public popularity. In the UK, this dietary approach 
reached the mainstream after a BBC Horizon documentary aired in August 2012, featured an 
intermittent fasting approach called the 5:2 diet.  The diet involved five days of regular eating patterns 
interchanged with two days of “fasting” (daily maximum of 500kcal for women and 600kcal for men) per 
week. In addition to the popular 5:2 approach, there are a number of other intermittent fasting patterns 
used to describe this dietary treatment approach, including alternate day fasting (ADF), periodic fasting 
or intermittent energy restriction (IER) for two up to six days per week. The premise of this approach to 
dieting involves interspersing normal daily caloric intake with short periods of severe calorie 
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restriction/fasting. It does not involve a true fast which would consist of complete abstinence from food 
and/or water, intermittent fasting involves changing the “usual” daily energy intake to a much lower 
calorie intake. For the purpose of this review, the term IER will be used to describe all intermittent fasting 
regimens. 
The potential health benefits and biological processes of IER are not well establised.11,12 There is some 
evidence, predominantly from animal studies, to demonstrate beneficial effects from weight loss and 
additional improvements on cardio-metabolic risk factors.  It has been hypothesised that the mechanism 
for the possible additional benefits were through fat utilization and nutritional stress.13 
IER is achieved predominantly through intermittent periods of dietary intake based on a very low calorie 
diet (VLCD). However, currently international clinical guidance on the treatment of adult obesity does 
not recommend the routine use of VLCD (defined as a hypocaloric diet of 800 or less kcal/day) for the 
treatment of adult obesity.4,5,14,15 Instead, continuous energy restriction (CER) involving a daily energy 
deficit of 600 kcal/day is recommended as part of a multi-component weight management strategy, 
including ongoing support, and a maximum intervention duration of 12 weeks.4 In order for IER to be 
considered as an alternative approach to weight management, systematic evaluation of the current 
evidence base is necessary to provide support for this novel treatment over current practice (CER). 
Despite the recent popularity of IER16 and associated weight loss claims,17 the supporting evidence 
base to justify the use in humans remains limited with only one published systematic review13 at the 
time of the search examining the health benefits of this approach. The aim of this published review13 
was to examine the impact of IER interventions on wider health benefits including coronary artery 
disease risk of risk of diabetes (not specifically as a treatment approach for overweight and obesity). 
However, it did not examine the efficacy of studies which were consistent with clinical recommendations 
on a minimum 12 week intervention period, provide a critical appraisal of the methodology, or meta-
analysis of weight loss outcomes. Therefore, the aim of the current review is to address these gaps in 
the evidence base. 
This review was conducted according to an a priori published protocol.18 
Objective 
The objective of this study was to systematically review the available evidence and quantify the effect 
of intermittent energy restriction in the treatment for overweight and obesity in adults, when compared 
to usual care treatment (continuous energy restriction) or no treatment (ad libitum diet). 
Inclusion criteria 
Types of participants 
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This review considered studies that included free-living (not hospitalised) male and female adults aged 
18 years and over who were overweight or obese (i.e., had a body mass index (BMI) greater than or 
equal to 25 or 30 kg/m2, respectively). Participants were excluded if they had secondary or syndromic 
forms of obesity or were diabetic, previously had or were undergoing bariatric surgery, were pregnant 
or breast feeding, and were taking medication associated with weight loss (e.g. orlistat, metformin) or 
weight gain (e.g. steroids, antipsychotics). 
Types of intervention(s)/phenomena of interest 
This review considered studies that evaluated intermittent fasting interventions (defined as consumption 
of 800 kcal or less on at least one day, but no more than six days in a calendar week). As there is no 
accepted formal definition of ‘fasting,’ the clinically recommended5 upper limit for a very low calorie diet 
was used (800 kcal) in this review based on clinical recommendations.5 Interventions were included if 
they provided a follow up period of participants of at least 12 weeks from the start of the intervention.  
Types of comparators 
Interventions were compared to control (no intervention) or usual care (which consisted of advice to 
continuously follow a reduced calorie diet of approximately 25% of estimated daily energy 
requirements). 
Types of studies 
The review considered both randomized controlled and pseudo-randomized controlled trials for 
inclusion.  
Types of outcomes 
The primary outcome of the review was change in body weight. Secondary outcomes included in this 
review were change in BMI, waist circumference, fat mass, fat free mass, blood glucose and insulin, 
lipoprotein profiles, blood pressure, diet, physical activity, quality of life, and adverse events (such as 
physical or psychological side effects from taking part in the interventions). 
Outcomes measures were only included in the meta-analysis if they were measured objectively, used 
validated tools and procedures. 
Search strategy 
The search strategy aimed to find peer reviewed published studies, clinical trials, and grey literature 
such as reports and conference proceedings. A three-step search strategy was utilized in this review. 
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An initial limited search of MEDLINE and CINAHL was undertaken followed by analysis of the text words 
contained in the title and abstract, and of the index terms used to describe the article. A second search 
using all identified keywords and index terms was undertaken across all included databases. Thirdly, 
the reference list of all identified reports and articles was searched for additional studies. Only studies 
published in English language and published up to November 2015 were considered for inclusion in 
this review. 
The databases searched include:  
Medline via OVID Host  
Embase via OVID  
CINAHL via EBSCO Host  
Cochrane Central Register of Controlled Trials (CENTRAL)  
The search for protocols and trials included:  
Clinicaltrials.gov  
ISRCTN registry  
anzctr.org.au  
Initial keywords to be used were: intermittent fasting or periodic fasting, ADF or intermittent calorie 
restriction, and overweight or obesity. The full search strategy is available in Appendix I. 
Methodological quality of included studies 
Quantitative papers selected for retrieval were assessed by two independent reviewers for 
methodological validity prior to inclusion in the review using standardized critical appraisal instruments 
from the Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument (JBI-
MAStARI) (Appendix II). To be considered adequate quality, the randomized and pseudo-randomized 
trials had to achieve a minimum six out of 10 quality appraisal questions. Any disagreements that arose 
between the reviewers were resolved through discussion, or with a third reviewer. 
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Data extraction 
Data were extracted from papers included in the review using the standardized data extraction tool from 
JBI-MAStARI (Appendix III). The data included specific details about the interventions, populations, 
study methods, and outcomes of significance to the review question. 
Data synthesis 
Quantitative data were, where possible, pooled in statistical meta-analysis using Comprehensive Meta-
Analysis software (Version 3.0 for Windows: Biostat, Englewood, Colorado, USA). All results were 
subject to double data entry. Effect sizes were expressed as weighted mean differences (WMD) (for 
continuous data, calculated from the last available measure) and their 95% confidence intervals were 
calculated for analyses. Three studies did not report the standard deviation of the mean change.19-21 
Therefore, these were calculated using an imputed correlation coefficient, calculated from the variance 
of pre- and post-, and change in outcome variable from available data from Bhutani et al.22. One study 
investigated the effects of two formats of IER in comparison to CER.20 To create a single pair-wise 
comparison, and to prevent multi-comparisons and a unit-of-analysis error, IER interventions in the 
aforementioned study were combined. Heterogeneity was assessed statistically using the standard I-
squared and tau-squared. Where possible, subgroup analyses were considered based on baseline 
weight status of participants (i.e., overweight [BMI: 25-29 kg/m2], obese [BMI: 30-39 kg/m2] & morbidly 
obese [BMI 40+ kg/m2]); gender; age; length of study, and IER approach. Where statistical pooling was 
not possible, the findings are presented in narrative form including tables and figures to aid in data 
presentation where appropriate. 
GRADE assessment 
GRADE assessment was conducted to assess the overall quality of evidence.23 GRADE assessment 
is made up of risk of bias to the internal validity of results, consistency of results across studies, 
directness and precision of results, and likelihood of publication bias. The overall quality of evidence is 
then categorised as high, moderate, low or very low. GRADE assessments were conducted for the 
primary outcome included in the meta-analysis (GRADE Tables are presented in Appendix IV). Two 
independent researchers (LA and LH) performed the GRADE assessments and consensus agreed.  
Results 
Literature search 
The systematic search identified 69097 studies. After removing duplicate studies, 61,328 titles and 
abstracts were reviewed. Full text articles were sought for 119 studies and their eligibility for inclusion 
in this review assessed. One hundred and ten articles were excluded based on the reasons illustrated 
in Figure 1. Nine studies were considered eligible. Three of these studies were identified from the clinical 
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trials register and were considered ongoing studies, with final results not published at the time of the 
search. Six studies reported adequate outcome data and were included in this systematic review and 
meta-analysis. 
 
INSERT Figure 1: PRISMA flow diagram of search and study selection process (Adapted from 
Moher et al.24) 
 
Methodological quality 
Two out of the six studies were randomized controlled trials20,22 based on the definition used by the JBI-
MAStRI critical appraisal tool (Appendix II). The remaining studies were pseudo-randomized studies, 
as they did not clearly define the process of random allocation of participates to treatment conditions 
(Q1). The results for each quality assessment question by study are presented in Table 1. Three studies 
met the minimum six ‘Yes’ scores out of 10 (refer to appendix II) and therefore were considered of 
adequate methodological quality.19,20,22 None of the studies blinded participants to treatment allocation 
(Q2) and only one study20 clearly reported allocation to treatment groups was concealed from the 
allocator (Q3), with the remaining studies judged as unclear due to limited reporting of this outcome. 
This was consistent with blinding of outcome assessors to treatment allocation(Q5), with the 
aforementioned study reporting participants were not blinded and the remaining studies unclear in their 
reporting of this outcome.  Three studies did not include outcomes of people who withdrew in the 
analyses.21,25,26 One study did not meet the criteria for question six (were the control and treatment 
groups comparable at entry?) and one study did not fulfil question nine (Were outcomes measured in a 
reliable way?).21,25 Differences in baseline characteristics between the treatment groups did not appear 
to be considerably different in the study by Hill et al.21 However, no statistical test of differences in 
baseline characteristics was described, this was reviewed as unclear. Again, limited reporting, of 
outcome measures meant that question nine was also assessed as unclear in the study by Viegener et 
al.25 The reviewers judged that insufficient reporting of methodology limited these studies meeting the 
criteria for a ‘yes’ in questions six and nine and likely not a limitation in the conduct of the methodology. 
All studies fulfilled the ‘Yes’ criteria for treating intervention groups identically (Q7), consistency in 
measuring outcomes for all interventions (Q8), and providing appropriate statistical analysis (Q10). In 
addition to the risk to the internal validity of studies assessed by the JBI-MAStRI critical appraisal tool, 
high rates of attrition (> 20%) were reported in four out of the six studies (table 1). Rates of attrition 
were comparable between intervention groups with the exception of Bhutani et al.22 which had no drop 
outs in the control intervention in comparison to nine participants from the IER intervention. 
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INSERT: Table 1: Assessment of methodological quality 
 
Study characteristics 
A summary of the characteristics of the six included studies is detailed in Table 2. The majority of studies 
were in general conducted in the USA (n=4), with the exception of two studies by Harvie and colleagues 
conducted in the UK.19,20 Four studies investigated the efficacy of IER interventions in comparison to 
CER19-21, 25 and two studies included a no treatment control intervention (ad libitum diet) as the 
comparator. The mean duration of the interventions was 5.6 months (range: 3 to 12 months), with only 
one study conducting follow up outcome measures at six months post intervention.21 The majority of 
studies focused their intervention on weight loss, with only two studies including a weight maintenance 
phase.20,25 In addition to examining the efficacy of calorie restriction regimens, the effects of exercise 
interventions were also investigated in two studies.21,22 Bhutani et al.22 included four intervention groups; 
ADF, exercise, combination (both exercise and ADF) and a control group, while Hill et al.21 examined 
the efficacy of four interventions of, ADF and CER with and without exercise. As the primary aim of the 
review was focused on the efficacy of dietary restriction regimens, results are not presented for 
participants involved in the above exercise interventions. All studies measured body weight as their 
primary outcome. Additional anthropometric outcomes included fat mass, fat free mass, and waist 
circumference. BMI26 and other circumferences measures (bust and thigh) 19,20 were reported in few 
studies but not included in the meta-analysis. Secondary outcome measures varied across studies; the 
most commonly reported were cardio-metabolic biomarkers including lipoprotein profiles, glucose, and 
insulin (presented in Table 3) and less commonly reported were satiety hormones (leptin and 
adiponectin) and inflammatory markers [including Interleukin 6 (IL-6) and Tumour Necrosis Factor 
Alpha (THF- α)].  
 
INSERT Table 2: Overview of included studies. 
 
Participant characteristics 
A total of 400 participants were enrolled in the studies (excluding participants in the exercise 
interventions). The mean sample size was 67 participants (range: 20-115 participants) and a mean of 
31 participants per intervention (range: 10 to 54 participants). The mean age of participants in each 
study ranged from 37 years to 49 years. Participants were overweight or obese (mean BMI range 26.0 
kg/m2 to 35.6 kg/m2). The ethnicity of the participants was only reported in three studies.19,20,26 The 
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majority of participants were Caucasian (range: 46% to 97%). Other ethnic origins included African 
American (46%); Afro Caribbean (2%); Hispanic (10%) and ethnic origin classified as other (2%). Socio 
economic status (SES) was not reported across studies. However, an indication of employment level, 
relevant to SES, was reported in two studies.19,20 The majority of participants were in full time 
employment (range: 64% to 82%), followed by part time employment (range: 14% to 19%). Seventeen 
percent were reported to be retired or unemployed. The majority of studies involved only female 
participants with the exception of two studies which included both genders; however, females were 
primarily enrolled, with only 10 men participating in total across all studies.22,26 Participants were 
considered in general to be healthy, and were not reported to have any obesity related health conditions 
such as type II diabetes or cardiovascular disease. Five participants were reported to have hypertension 
a condition associated with the development of chronic conditions.19 Participants in the studies by 
Harvie et al.19,20 were at increased risk of developing breast cancer by virtue of a positive family history 
but had no personal history of breast cancer.  
INSERT Table 3: Change in weight, anthropometric, and cardiometabolic outcomes of primary 
studies. 
Interventions 
Dietary protocols for IER varied across studies from a minimum two days fasting per calendar week up 
to four days. Two studies utilized an alternative day fasting followed by a “feed day”.22,26 Participants 
had to consume their total energy intake on fast days between 12pm and 2pm to allow a 24 hour fasting 
period. Two studies prescribed fasting on two consecutive days19,20 and two studies included three or 
more days of fasting.21,25 Hill et al.21 altered the number of days of reduced energy intake from three to 
seven with a set pattern prescribed from weeks 1-5 and 7-12. Dietary intake on fast days was restricted 
to 25%-40% in four studies.19,20,22,25,26 Daily energy restriction in the study by Hill et al.21 ranged from 
600 kcal to 1500 kcal.21,25 On non-energy restriction days participants ate ad libitum in the ADF 
regimens22,26 and energy intake was restricted to between 60% -75% of total energy intake in 
conjunction with estimated requirements for weight maintenance19,20,25. The macronutrient composition 
of the IER diets were primarily based on recommendations for a healthy balanced diet27 to include 55% 
energy from carbohydrate, 25-30% fat, and 15-20% protein18,19,22. Two studies limited energy intake on 
fasting days solely to protein19,20 and one study only provided recommendations on restricting dietary 
intake of fat to less than 15% on energy restriction days. 
Energy restriction in the CER interventions ranged from 25%-30% of daily energy requirements. 
Macronutrient composition of prescribed diets was again based on recommendations for a healthy 
balanced diet27 as discussed above. Interventions comparing IER to no treatment allowed for ad libitum 
energy intake.  
In addition to the dietary interventions, two studies provided an exercise component, which ranged from 
advice on physical activity and providing an information booklet focused on home based activities 
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(including walking, strength, and flexibility exercises)20 to a more structured exercise aerobic program 
with an aim of 30 minutes of walking or stationary cycling activity six days a week.25 Exercise 
components were consistent across both treatment groups. Four studies did not provide any exercise 
component and participants were advised to maintain their habitual physical activity.19,21,22,26 As 
previously mentioned, interventions which primarily focused on the efficacy of exercise were excluded 
from this review. 
Adherence/Compliance 
Measuring adherence to dietary advice is always challenging due to the subjective nature of self-report 
dietary intake and a lack of valid objective measurements.28 All studies with the exception of Bhutani et 
al.,22 utilized self-report measures of dietary intake through food diaries as a measure of adherence/ 
compliance to the dietary regimen. Based on the self-report measures, compliance with diets (IER and 
CER) was high (mean adherence range: 58% to 98%) and not different between treatments. 
Furthermore, adherence to IER regimens appeared not to be affected with increased number of fasting 
days (i.e., fasting for 2 days19,20 or 4 days per week21,25).  
Effects of interventions 
Primary outcome change in body weight 
Meta-analysis was conducted for four studies that included CER as a comparator intervention.19-21,25 
Both interventions achieved comparable weight losses and there were no significant differences in 
change in body weight between interventions (WMD: -1.03 kg; 95% CI -2.46 kg to 0.40 kg; p = 0.156; 
Figure 2). Statistical heterogeneity was not present (Q (3) 1.2, P = 0.76 I2 = 0.0%). Only one study 
examined the efficacy of IER at 12 months, illustrating that weight loss could be sustained long term 
equivalent to that following CER.25  
 
INSERT Figure 2: Weighted mean difference in body weight (kg) between the intermittent 
energy restriction interventions and continuous energy restriction interventions. 
 
Secondary anthropometric outcome 
Secondary outcomes of interest in this review were other measures of body composition and cardio-
metabolic markers. Few studies consistently reported anthropometric outcomes. The results for change 
in outcomes are primarily from the studies conducted by Harvie and colleagues.19,20 Pooled effect sizes 
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across these studies revealed significant reductions in waist circumference (WMD: -2.14 cm; 95% CI -
3.53 cm to -0.75 cm; p = 0.002) and in fat mass (WMD: -1.38 kg; 95% CI -2.47 kg to -0.28 kg; p = 0.014) 
for the IER intervention in comparison to CER (Table 4). 
Secondary cardio-metabolic outcomes 
Summary effect estimates for cardio-metabolic outcomes were only included for outcomes which were 
reported by two or more studies. Results again were primarily reported from the studies led by Harvie 
et al.19,20 Effect sizes for cardio-metabolic outcomes are presented in Table 4. There was a significant 
effect of IER in comparison to CER for improvements in insulin concentrations (WMD: -4.66 pmol/l -
9.12 pmol/l to -0.19 pmol/l; p = 0.041). However, there were no significant between group differences 
for IER in comparison to CER for lipoprotein profiles (Total cholesterol, LDL and HDL cholesterol and 
Triglycerides) or glucose concentrations. It is important to note that due to the limited number of studies 
included in this analysis of cardio-metabolic outcomes (n = 2; total cholesterol n = 3), results should be 
interpreted with caution. 
INSERT Table 4: Pooled effect sizes (WMD) of secondary outcomes. 
IER compared to no treatment control 
Primary outcome change in body weight 
Two studies assessed the efficacy of IER interventions in comparison to a no treatment control group. 
There was a significant difference between the IER interventions and no treatment (WMD: -4.14 kg; 
95% CI -6.30 kg to -1.99 kg; p ≤ 0.001; Figure 3). There was significant statistical heterogeneity in 
effect sizes (Q (1) 2.9, p = 0.09 I2 = 65.7%). The within group analysis revealed that in the study by 
Bhutani et al.22 the significant differences were due to a significant decrease in body weight in the IER 
regimen and no change in body weight following no treatment. Within group differences were not 
reported in the study by Varady et al.26 
 
INSERT FIGURE 3: WMD in body weight (kg) between the IER interventions and control 
interventions. 
Secondary anthropometric outcomes 
In addition to change in body weight, there was a significant between group effect of IER compared to 
no treatment on change in fat mass (WMD: -3.24 kg; 95% CI -4.55 kg to -1.92 kg; p ≤ 0.001).  
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Secondary cardio-metabolic outcomes 
The study by Varady et al.26 measured cardio-metabolic outcomes including lipoprotein profiles, 
however, due to the limited number of studies utilizing a control comparator, pooled effect sizes could 
not be calculated. The results revealed that there was no significant between group differences for total 
cholesterol, LDL and HDL cholesterol or triglycerides for the IER intervention in comparison to no 
treatment. Meta-analysis was conducted for blood pressure, with both studies reporting changes in 
systolic and diastolic pressures.22,26 There was no significant effect of IER in comparison to no treatment 
in changing either blood pressure measurement (table 4). 
Lifestyle outcomes 
Meta-analyses were not conducted to assess any change in diet, due to limited reliability of reporting 
and a lack of valid objective measurements. This was also applicable to measures of physical activity. 
Only three studies measured physical activity through self-report methodologies, using the International 
Physical Activity Questionnaire19 and physical activity diaries.20,25 In the study by Viegener et al.25 
recording of physical activity in a diary was included as an outcome. There were minimal and non-
significant changes reported with no between group differences. Quality of life was only assessed in 
two studies19,20 and the methodology across studies was not consistent (RAND SF-36 and Profile of 
Mood Scores). Irrespective of methodology used, improvements in quality of life were comparable 
across dietary treatments.  However, there was a significant increase in the mental health component 
summary score and indicating a slight improvement in quality of life in the CER group in comparison to 
the IER intervention in the study by Harvie et al.19 
Adverse events 
No serious adverse events were reported across studies. Three studies reported minor physical and 
psychological effects.19,20,26 These were in general reported for a small number of participants and were 
reported in both dietary interventions. The physiological effects included headaches (IER 8%), reduced 
energy levels (IER 4.9%; CER 5%), feeling cold (IER 4.8%; CER 3%), constipation (IER 6.4%; CER 
3%).  Light headiness and bad breath was reported on IER days for 3% and 8% of participants, 
respectively. Psychological effects in both interventions included a lack of concentration, pre-occupation 
with food, and mood swings (IER: range 3-15%; CER: range 3-7%). Adverse events were not reported 
in studies utilizing a no treatment control intervention.22,25 
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Discussion 
Principle findings 
This systematic review aimed to examine the efficacy of IER as an approach to weight management in 
comparison to current clinical practice (CER) or no treatment. Based on current evidence, the primary 
results of the meta-analysis revealed that IER is as effective as CER for short term weight loss.  Both 
conditions led to a comparable and substantial weight loss (~5-10 kg). However, the duration of the 
interventions was short (mean duration: 5.6 months; range: 3 months to 12 months) with only one study 
comprising a 12 month intervention in accordance with current clinical guidance.4,5,14,15 Results from 
this longer term study revealed that change in body weight was sustainable in both IER and CER 
conditions.25 There was a significant intervention effect of IER on waist circumference and body fat, in 
comparison to current CER. Raised waist circumference was the best anthropometric predictor of 
visceral fat, and signals both high BMI and central fat distribution.29 These results are promising as 
reductions in waist circumference or central fat distribution reduce cardiovascular risk.30 The reduction 
in waist circumference may partially explain the decrease in fasting insulin, though this is also likely to 
be associated with the periods of acute energy restriction, particularly in the IER group.  Waist changes 
of close to 9 cm reflect a clinically important weight change of close to 9 kg.30 However, the efficacy of 
changes in secondary anthropometric outcomes should be interpreted cautiously due to the limited 
number of studies. Future studies are required to assess the long term effects of IER as a treatment 
approach to weight management.  
The second element of the comparison is for the two studies for which IER was compared with a control 
group.  Both studies prescribed an ADF approach to intermittent fasting. As expected when offering no 
treatment as a comparator intervention, there was a significant effect of IER in comparison to the control 
intervention. A significant between group difference was also replicated in secondary anthropometric 
outcomes, waist circumference and percentage body fat. These results are consistent with the majority 
of weight management interventions.31 
Clinical effectiveness 
Clinical guidelines have concluded that in overweight and obese adults, a reduction in body weight of 
5-10% of initial body weight (or approximately 5-10 kg) was associated with improvements in health risk 
factors.4,5 None of the included studies investigating IER in comparison to CER reported percentage 
weight change as an outcome and whether or not participants achieved sufficient weight loss associated 
with improvements in health risk factors. However, weight loss based on between group changes in 
mean body weight revealed that mean weight loss (~ 7 kg) was of sufficient magnitude to be associated 
with clinical benefits in both the IER and CER interventions. This is an important finding illustrating that 
participants may have lost equivalent or even greater than the 5-10% target amount and thus provides 
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evidence that the IER may be a clinically important approach for weight management. For studies 
investigating the efficacy of IER in comparison to no treatment, mean percentage weight change was 
only reported in one study.20 Mean percentage weight change in this study was not of a magnitude 
associated with clinical benefits. Future studies, should aim to report percentage weight change and in 
particular weight change associated with improvements in health risk factors. 
Despite not reporting clinically important weight loss, studies reported measuring changes in cardio-
metabolic risk factors. The results for the efficacy of IER on cardio-metabolic outcomes in comparison 
to CER was primarily investigated by the two studies by Harvie et al.19,20 Summary estimates revealed 
that there was a significant reduction in insulin concentrations following IER in comparison to CER. A 
significant reduction in fasting insulin may potentially be explained in part due to the concomitant 
significant reduction in total body fat and central adiposity. Although the mechanisms of fasting on 
improvements on metabolic outcomes are yet to be defined, the improvement in insulin sensitivity is 
most likely to be associated with periods of acute energy restriction particularly on fasting days. 
However, moderate weight loss (-7% body weight) in obese adults without acute periods of energy 
restriction, has also shown improvements in insulin sensitivity after fasting via changes in cytokines, 
which are altered after weight loss.32 Therefore there is insufficient evidence to determine the acute 
mechanistic effects of fasting, though the mediator for these changes is moderate weight loss.33  
There was no significant difference in treatment approach on lipoprotein profiles or plasma glucose. 
Despite a lack of between group effect, both studies reported significant changes in concentrations from 
pre- to post-intervention. Although the significance of the change in cardio-metabolic outcome was 
reported, clinically meaningful changes were not. Comparison of change in outcomes with clinically 
important definitions (based on guidelines from evidence based practice4,5 and previous research 
examining clinical risk factor changes in patients with type II diabetes)34 revealed that in general 
changes in cardio-metabolic outcomes in these studies were not sufficient to offer health improvements 
with the exception of changes in total cholesterol21 and LDL cholesterol.26 It is important to note that the 
limited findings of clinical benefits should be interpreted with caution, as few studies consistently 
measured cardio-metabolic outcomes and limited reporting of outcomes prevented inclusion of all 
outcomes in the analysis. Furthermore, there were a number of additional biomarkers that were not 
included in the meta-analysis as they were only measured in one study. For example, IER appeared to 
affect the production of adiponectin this has a crucial role in insulin sensitivity, cancer progression, and 
development. However, due to the limited number of studies and sample sizes of studies, conclusions 
on the potential health benefits of IER are limited and future studies are warranted to elucidate the 
potential metabolic effects of IER. The evidence to date does not support any additional metabolic 
benefit of IER.  
Maintenance of body weight following a period of weight loss is an essential component to weight 
management. Evidence has demonstrated that individuals who have sustained changes in body weight 
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have been able to adhere to the new healthy lifestyle choices and remain at a reduced risk of adverse 
health conditions associated with weight gain.4,5 Only two of the interventions in this review included a 
weight maintenance phase of varying durations; of one month20 and six months.25 Weight loss was 
maintained in both interventions, providing evidence that IER might also be an effective strategy for 
preventing weight gain, following a period of weight loss. However, future studies with a weight 
maintenance period of adequate duration such as a minimum six months as recommended by clinical 
guidance is required to elucidate the long term effects on sustainability of weight loss and improvements 
in health risk factors. 
Comparison with previous research 
To the author’s knowledge, this is the first review to solely include randomized or pseudorandomized 
controlled trials. Previous reviews13,35,36 have included heterogeneous study designs and observational 
studies which induce bias such as un-measurable confounding factors and reverse causality. 
Randomized controlled trials are considered the criterion method to examining the effectiveness of an 
intervention37 and therefore, this review adds to the quality of the current evidence base. Furthermore, 
this review aimed to fill the gap reported by previous reviews by providing a more reliable estimate of 
the effect size of IER interventions through the inclusion of meta-analyses. The findings of the meta-
analyses are consistent with the conclusions of previous narrative reviews, in providing support for IER 
as an effective approach to weight management. Overall conclusions from the current evidence base 
and this review advocate the need for further high quality, randomized controlled trials to examine the 
long term efficacy and adverse effects of this dietary intervention in comparison to current clinical 
practice. 
Methodological limitations  
A limitation of the available literature is in relation to the study quality. Only two studies sufficiently 
described the process of allocation concealment to intervention groups and were considered to be truly 
randomized. Furthermore, most studies provided insufficient detail to determine whether outcome 
assessors were blinded to treatment allocation. Unblinded outcomes have shown to introduce bias in 
terms of exaggerating the effect size of interventions.38 Future studies should provide an adequate 
description of the procedures of randomization and conduct single blinded studies to ensure and confirm 
that studies are at reduced risk of potential bias. 
High attrition rates were evident in the IER intervention. This is comparable to previous reviews of 
weight management interventions,9,39-41 reporting attrition rates of between 30-60%. Attrition rates less 
than 20% indicate an intervention is acceptable and contributed in addition to rigorous study design (as 
assessed in the critical appraisal of the included studies) to a high quality study.42 The attrition rates 
were in general comparable across treatment groups, however, four studies reported greater than 20% 
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attrition. This is concerning due to the short duration of studies. Only one study reported attrition rate at 
12 months (IER 30.2%; CER 28.6%).25 This was not greater than the studies reporting attrition rates in 
general at three months. This illustrates that adherence to energy restriction periods of four days per 
week is not less than less intensive, two day energy restriction regimens. 
Sensitivity and subgroup analysis could not be performed due to the small number of studies included 
in this review. This prevented insight in particular into the optimum IER approach. However, the results 
suggest comparable post intervention weight losses across studies irrespective of dietary regimen. This 
is an important finding, although further research is necessary to investigate the optimum approach to 
deliver an IER regime. Given the complexity of weight management it is unlikely that a ‘one size fits all’ 
approach will work. This review therefore provides data to suggest that IER may provide an alternative 
approach for individuals who struggle with daily energy restriction. As compliance was measured by 
total weight change and was also comparable between IER and CER approaches, it suggests this may 
be an acceptable dietary regime. 
Generalizability of results 
The majority of participants included in this review were female. Two studies in particular were carried 
out on a specific group of women, who were at primary risk of developing breast cancer.16,17 The 
increased health risk in these women may have elevated their motivation, and thus may have achieved 
greater weight loss results than a less homogeneous group. There was also a lack of male participants 
(only 10 in the entire analysis),22,26 which highlights the need for more research on IER in this population. 
This gender imbalance was consistent with findings from a recent review.43 which supported the 
assertion that participants engaged in weight management programs are predominately female. 
Furthermore, the mean age range of participants was 37 years to 49 years and included primarily a 
homogeneous group of women. This raises question as to the generalizability of the findings to younger 
and older populations. This is important as young adults aged 18-24 years have been shown to be at 
an increased risk of weight gain as they transition from adolescence to adulthood.44 There is also a 
trend demonstrating increased onset of obesity in later life,45 yet despite the absence of an no upper 
age limit for inclusion of participants in the included studies, no older adults (≥ 65 years) participated. 
Further research examining the acceptability and effectiveness of IER in these population groups is 
certainly warranted. 
Examining potential health inequalities is paramount in any weight management program given the 
established links between low SES and poor uptake and high attrition.46 However, the studies included 
in this review provided very limited socio-economic data for their participants. A report on poverty in the 
UK47 suggested that individuals with short term outlooks on life, enforced due to financial and other 
pressures, are less likely to be motivated to participate in interventions such as weight 
management.  Therefore, consideration must be given to encourage uptake from a broader cross 
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section of society in order to evaluate efficacy in all populations, not just those who are most likely to 
engage. This is important in terms of wider roll out and ensuring that new interventions narrow, not 
broaden existing inequalities.  
Current evidence only provides data for populations from the UK and USA. As different countries and 
cultures may experience different motivators and barriers to weight management, it is important that 
further IER research is conducted across a more geographically diverse population before the 
international applicability of the findings can be fully evaluated. 
Research implications 
This systematic review provides evidence for the efficacy of IER (which can be considered a ‘complex’ 
intervention) as an approach to short term weight management. Recent guidelines by the Medical 
Research Council (MRC) on developing and evaluating interventions advocate that new treatment 
approaches should undertake a program of research from feasibility testing (including process 
evaluation and economic evaluations) to rigorous randomized controlled trials to examine the efficacy 
of the intervention.37,48 The studies in this review were not of high quality and had low methodological 
rigor and short intervention and follow-up duration. Future studies are required to determine the efficacy 
of IER under more quality assured conditions, including blinding of outcome measures, adequate 
description of randomization procedures, and reporting of outcome measures. Research 
recommendations from this review include the need for more adequately powered, high quality, large 
scale randomized control trials conducted in different countries with a more heterogeneous mix of 
participating genders and age ranges. Feasibility testing should investigate methods to maintain 
motivation throughout the interventions and prevent high attrition rates. The studies in this review were 
predominantly focused on examining the efficacy of the interventions in relation to their primary and 
secondary outcomes, and thus valuable measures in relation to the processes of delivering these 
dietary interventions were not investigated. Indeed, process evaluation has been highlighted of 
increasing importance in advancing the understanding of complex interventions.49 Process evaluations 
provide opportunities to identify the successful and unsuccessful components of an intervention and 
are often enriched by utilizing qualitative methods.50,51 Future IER research would benefit from more 
detailed process evaluation to identify barriers and facilitators to this approach, and which populations 
may gain most benefit and why. 
As research in this field continues, it is hoped some of the limitations of the current evidence base will 
be addressed. This review identified three ongoing studies which met the inclusion criteria for this 
review. One study was conducted in the USA [(NCT00960505, 2016) which had not reached 
completion] and two conducted in Norway [(NCT02169778, 2016) (NCT02480504, 2016) which had 
reached completion but had not published any findings], which will help address the international 
application of this approach. The three ongoing studies focus on IER regimens including ADF 
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(NCT00960505, 2016); 5:2 (NCT02480504, 2016) and 3 days (NCT02169778, 2006) with two studies 
comparing IER to CER, and one comparing IER to no treatment control (NCT00960505, 2016). Two 
studies [(NCT02480504, 2016), (NCT02169778, 2006)] appeared to adhere to clinical guidelines and 
measured outcomes at 12 months and included body weight and cardio-metabolic outcomes. Thus, the 
results of these will add to the current body of research and may potentially help elucidate the long term 
effects and sustainability of IER and any changes in weight loss and health risk factors.  
As the popularity in IER increases, clear definition on what IER actually constitutes needs to be 
established. For the purpose of this review, IER was defined as energy restriction periods of up to six 
days per week. However, additional studies identified during the systematic search, found that studies 
also explored longer term IER regimens (greater than one week). Future reviews should consolidate 
the evidence base on longer term periods of IER and whether they are an effective approach to weight 
management. 
Clinical implications 
The main aim of any dietary intervention is for it to become implemented in routine practice. Currently 
there is insufficient evidence to make any firm recommendations as to the routine use of IER, given the 
small number of variable quality studies, with very little follow up and limited generalizability. However, 
further studies will help to examine the long termer impact of this approach, providing more robust data 
to determine whether the short term changes and benefits that have been demonstrated in this evidence 
synthesis and meta-analysis, are persistent over time, and across different populations. As clinical 
guidelines require interventions that are deemed both clinically and cost effective4, economic 
evaluations of this approach are also required. 
Conclusion 
This systematic review provides an update on the available evidence for the efficacy of IER as an 
approach to weight management. Few studies met the inclusion criteria which aimed to reflect current 
practice for the management of obesity. Furthermore, studies were of variable quality with inadequate 
follow up and limited generalizability. Meta-analyses revealed that both IER and CER resulted in similar 
weight loss, therefore, IER is as effective as CER and for short term weight loss in overweight and 
obese adults. IER was shown to be more effective than no treatment, however, this should be 
interpreted cautiously due to the small number of studies and future research is warranted to confirm 
the findings of this review. 
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Figure 1: PRISMA flow diagram of search and study selection process (Adapted from Moher et 
al.24) 
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69097 records identified through 
database searching 
6 of studies included in the meta-analysis. 
9 studies included in the review: 
- 4 from search strategy,  
- 2 from hand search 
- 3 ongoing studies (clinical trial registry 
entry – no published data) 
119 of full text articles assessed for 
eligibility 
61209 of records excluded 61328 records title and abstract screened 
2 records identified through hand 
searches 
 61328 records after duplicates removed 
 
110 of records excluded: 
- not RCT:  10 
- not in English:  2 
- intervention <12wks: 5 
- reviews:  11 
- fasting criteria not met      2 
- control criteria not met      5 
- incorrect population 9 
- not IER  60 
- animal study  3 
- could not be located 3 
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Table 1: Assessment of methodological quality. 1 
Citation Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Total 
  
 
Bhutani et al.22 
Y N U U U Y Y Y Y Y 6 
Harvie et al.19 U N U Y U Y Y Y Y Y 6 
Harvie et al.20 Y N Y Y N Y Y Y Y Y 8 
Hill et al.21 U N U N U U Y Y Y Y 4 
Varady et al.26 U N U N U Y Y Y Y Y 5 
Viegener et al.25 U N U N U Y Y Y U Y 4 
% 33.33 0.00 16.67 33.33 0.00 83.33 
 
 
 
100.00 100.00 83.33 
 
100.00  
  Y = Yes; N = No; U = Unclear 2 
Q1. Was the assignment to treatment groups truly random? 3 
Q2. Were participants blinded to treatment allocation? 4 
Q3. Was allocation to treatment groups concealed from the allocator? 5 
Q4. Were the outcomes of people who withdrew described and included in the analyses? 6 
Q5. Were those assessing outcomes blind to treatment allocation? 7 
Q6. Were the control and treatment groups comparable at entry? 8 
Q7. Were groups treated identically other than for the named interventions? 9 
Q8. Were outcomes measured in the same way for all groups? 10 
Q9. Were outcomes measured in a reliable way? 11 
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Q10. Were appropriate statistical analyses used? 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
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Table 2: Overview of included studies. 1 
 2 
Reference                 Study population Intervention Study 
duration 
(Months) 
Attrition 
  IER CER/ 
Control 
IER CER/Control   IER CER 
Bhutani et 
al.22 
Weight (kg): 
BMI (kg/m2): 
Age (years): 
Gender (F/M): 
 
 
94.0 ± 3.0 
35.0 ± 1.0 
 
42.0 ± 2.0 
24/1 
93.0 ± 5.0 
 
35.0 ± 1.0 
 
49.0 ± 2.0 
15/1 
ADF: 75% energy 
restriction on fast 
days (24h) consumed 
between 12 pm & 2 
pm & ad libitum on 
each alternating feed 
day (24 h). 
 
Macronutrient 
composition: 
Control: Ad libitum 
dietary intake 
Weight loss: 
3  
 
Enrolled: 
Completed: 
Attrition 
rate:  
n = 25 
n = 16 
36.0% 
n =16 
n = 16 
0.0% 
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55% CHO; 25% FAT; 
20% PRO (food 
provided on fast days 
for controlled feeding 
phase weeks 1-4) 
 
Harvie et 
al.19 
Weight (kg): 
BMI (kg/m2): 
Age (years): 
Gender (F/M): 
 
 
81.5 (13.1) 
 
30.7 (5.0) 
 
40.1 (4.1) 
53/0 
84.4 (16.4) 
 
30.5 (5.2) 
 
40.0 (3.9) 
42/0 
IER: 2 consecutive 
fast days (75% 
restriction. ~500 
kcal/day) & to 
consume estimated 
requirements for 
weight maintenance 
for the remaining 5 
days 
 
Macronutrient 
composition: 
50 g PRO/day  
 
CER: Daily 25% 
restriction (~ 1200-
1800 kcal /day) 
 
Macronutrient 
composition: 
45 % CHO; 30% FAT; 
25% PRO 
 
Weight loss: 
6 
 
Enrolled: 
Completed: 
Attrition 
rate: 
n = 53 
n = 42 
20.8% 
n = 54 
n = 47 
13.0% 
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Harvie et 
al.20 
 
Weight (kg): 
BMI (kg/m2): 
Age (years): 
Gender (F/M): 
 
Weight (kg): 
BMI (kg/m2): 
Age (years): 
Gender (F/M): 
 
IER 
79.4 (14.7) 
29.6 (4.1) 
45.6 (8.3) 
37/0 
IER+PF 
 
82.4 (16.4) 
 
31.0 (5.7) 
 
48.6 (7.3) 
 
40/0 
 
 
86 (17.3) 
 
32.2 (5.6) 
 
47.9 (7.7) 
38/0 
IER: 2 consecutive 
fast days (70% 
restriction, ~ 600-650 
kcal /day) & 5 days 
(25% restriction. ~ 
1200 - 1800 kcal 
/day) 
 
Macronutrient 
composition 
250 g PRO/day & 
restricted 40g CHO 
 
 
IER+PF: Energy 
requirements as for 
IER with addition of 
ad libitum PRO/FAT 
 
CER: Daily 25% 
restriction (~ 1200-
1800 kcal /day) 
 
Macronutrient 
composition: 
45% CHO; 30% FAT; 
25% PRO 
 
Weight loss: 
3 
 
Weight 
maintenance: 
1 
 
Enrolled: 
Completed: 
Attrition 
rate: 
 
 
 
 
Enrolled: 
Completed: 
Attrition 
rate: 
IER 
n = 37 
n = 33 
10.8% 
 
IER+P
F 
n = 40 
n = 27 
32.5% 
n = 38 
n = 28 
26.3% 
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Hill et al.21 Weight (kg): 
BMI (kg/m2): 
Age (years): 
Gender (F/M): 
 
 
85.8 (NR) 
 
31.0 (2.0) 
 
40.0 (5.0) 
10/0 
86.3 (NR) 
 
31.0 (3.0) 
 
37.0 (11.0) 
10/0 
Energy intake altered 
between 600 kcal/d 
&1500 kcal/day on a 
weekly regimen of 
fasting from 3 to 7 
days/week. 
 
Macronutrient 
composition: 
55% CHO; 25% FAT; 
20% PRO 
 
CER: Daily restriction 
of 1200 kcal/day. 
 
Weight loss: 
3 
Follow Up: 6 
Enrolled: 
Completed: 
Attrition 
rate: 
 
Completed: 
Attrition 
rate: 
n = 10 
n = 6  
40.0% 
Follow 
up  
n = 4 
60.0% 
n = 10 
n = 8 
20% 
Follow 
up 
n = 3 
70% 
Varady et 
al.26 
Weight (kg): 
BMI (kg/m2): 
Age (years): 
Gender (F/M): 
 
 
77.0 ± 3.0 
 
26.0 ± 1.0 
 
47.0 ± 3.0 
10/5 
77.0 ± 3.0 
 
26.0 ± 1.0 
 
48.0 ± 2.0 
12/3 
ADF: 75% energy 
restriction on fast 
days (24h) consumed 
between 12 pm & 2 
pm & ad libitum on 
each alternating feed 
day (24 h) 
 
Control: 
Ad libitum dietary 
intake 
 
Weight loss: 
3 
 
Enrolled: 
Completed: 
Attrition 
rate: 
n = 16 
n = 15 
6.3% 
n = 16 
n = 15 
6.3% 
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Macronutrient 
composition: 
55% CHO; 30% FAT; 
15% PRO 
 
Viegener 
et al.25 
Weight (kg): 
BMI (kg/m2): 
Age (years): 
Gender (F/M): 
 
94.7 (12.7) 
 
35.0 (NR) 
47.1 (7.49) 
 
43/0 
 
98.6 (15.9) 
 
35.6 (NR) 
 
47.1 (8.86) 
42/0 
4 days/ per week at 
800 kcal & 3 days/per 
week at 1200 kcal 
 
Macronutrient 
composition 
Restrict intake of FAT 
to ≤25% on 1200 kcal 
days & to ≤15% 800 
kcal days. 
 
CER: Maintenance 
of 1200 kcal /day 
 
Macronutrient 
composition 
55% CHO; 30% FAT; 
15% PRO  
 
 
 
Weight loss: 
6 
Weight 
maintenance: 
6 
 
Enrolled: 
Completed: 
Attrition 
rate: 
n = 43 
n = 30 
30.2% 
n = 42 
n = 30 
28.6% 
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Values represent Mean ± SEM; Mean (SD).  IER = Intermittent energy restriction; IER+PF = Intermittent energy restriction with ad libitum protein nad 1 
fat intake;CER = Continuous energy restriction; CHO = Carbohydrate; F = Female; M = Male; NR = Not reported; PRO = Protein 2 
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Question: Intermittent energy restriction compared to usual care for treatment for overweight and obesity in adult population  1 
Setting:  2 
Bibliography:  3 
Quality assessment 
№ of patients Effect 
Quality Importance 
№ of 
studies 
Study 
design 
Risk of bias Inconsistency Indirectness Imprecision Other considerations 
intermittent 
energy restriction 
usual care 
Absolute 
(95% CI) 
Weight (kg) 
4  randomised 
trials  
serious a not serious  serious b serious c all plausible residual 
confounding would reduce 
the demonstrated effect 
dose response gradient  
161  126  MD 1.03 lower 
(2.46 lower to 0.1 higher) 
⨁⨁⨁◯ 
MODERATE  
IMPORTANT  
CI: Confidence interval; MD: Mean difference 4 
a. Two out of the four included studies present high risk of bias for: performance, detection and attrition  5 
b. There was a serious risk of indirectness due to the limited age range of participants and gender distribution.  6 
c. There was serious imprecision considering the small number of studies and events and wide confidence interval.  7 
 8 
Question: Intermittent energy restriction compared to no treatment control for treatment overweight or obesity in adults  9 
Setting:  10 
Bibliography:  11 
Quality assessment 
№ of patients Effect 
Quality Importance 
№ of 
studies 
Study 
design 
Risk of bias Inconsistency Indirectness Imprecision Other considerations 
intermittent 
energy restriction  
no treatment 
Absolute 
(95% CI) 
Weight (kg) 
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Quality assessment 
№ of patients Effect 
Quality Importance 
№ of 
studies 
Study 
design 
Risk of bias Inconsistency Indirectness Imprecision Other considerations 
intermittent 
energy restriction  
no treatment 
Absolute 
(95% CI) 
2  randomised 
trials  
serious a very serious b serious c serious d strong association 
all plausible residual 
confounding would reduce 
the demonstrated effect 
dose response gradient  
31  31  -  
MD 4.14 mean difference lower 
(6.30 lower to 1.99 lower)  
⨁⨁◯◯ 
LOW  
IMPORTANT  
CI: Confidence interval; MD: Mean difference 1 
a. There was high risks of bias including: performance and detection bias  2 
b. There was serious inconsistency with high and significant heterogeneity  3 
c. There was a serious risk of indirectness due to the limited age range of participants and gender distribution  4 
d. There was serious imprecision considering the small number of studies and events and wide confidence interval.  5 
 6 
 7 
 8 
 9 
 10 
 11 
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 1 
Table 3: Change in weight, anthropometric, and cardiometabolic outcomes of primary studies. 2 
Reference Weight change (kg) Anthropometric changes Cardiometabolic changes 
 IER CER/ 
Control 
IER CER/ 
Control 
IER CER/ 
Control 
Bhutani 
et al.22 
   Waist circumference (cm) Systolic blood pressure (mm/Hg) 
 -3.0 (0.0)*  0.0 (0.0)NS -5.0 ±1.0* 
 
 
 -1.0 ± 1.0 NS 
 
 
 
-3.0 ± 1.0+ 
 
 
 -2.0 ± 3.0 NS 
 
 
 
    Fat mass (kg) Diastolic blood pressure (mm/Hg) 
    -2.0 ± 1.0+  0.0 ± 1.0 NS -2.0 ± 2.0+  -2.0 ± 3.0 NS 
Harvie et 
al.19 
   Waist circumference (cm) Glucose (mmol/l) 
 Pre Pre Pre 
 81.5 
(77.5-85.4) 
 84.4 
(79.7-89.1) 
 
101.5 
(97.8-105.2) 
 
 102.5 
(98.7-106.3) 
 
4.8 
(4.7-4.9) 
 
 4.8 
(4.6-4.9) 
  Post Post Post 
 75.8 
(71.4-0.2)+ 
 79.9 
(74.6-85.2)+ 
95.4 
(91.3-99.5)+ 
 
 98.6 
(94.2-102.9) + 
 
4.7 
(4.6-4.8) + 
 4.7 
(4.6-4.9)NS 
    Fat mass (kg) Insulin (mU/ml) 
     Pre Pre 
    33.6 
(30.9-36.4) 
 35.3 
(31.9-38.7) 
 
7.3 (6.3-8.4) 
 
 7.4 (6.4-8.6) 
 
    Post Post 
    29.1 
(26-32.3) + 
 
 31.7 
(27.9-35.5) + 
5.2  
(4.5-6.0) + 
 
 6.3  
(5.4-7.4) + 
    Lean Mass (kg) Systolic blood pressure (mm/Hg) 
     Pre Pre 
    47.6  
(46.3-49.0) 
 49.1 
(47.7-50.5) 
115.2 
(111.2-119.2) 
 116.8 
(113.1-120.4) 
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    Post Post 
    46.4 
 (44.9-47.9) + 
 
 48.3  
(46.7-49.9) + 
111.5 
(107.7-115.2) + 
 
 109.3 
(105.3-113.2) 
+ 
 
       Diastolic blood pressure (mm/Hg) 
        Pre 
       76.7 
 (73.9-79.4) 
 
 
 75.4  
(72.3-78.4) 
        Post 
       72.4 
 (68.9-76) + 
 
 69.7  
(66.4-72.9)+ 
        Total cholesterol (mmol/l) 
        Pre 
       5.1 (4.9-5.4)  5.2 (5.0-5.4) 
 
       Post 
       4.8 (4.5-5.0) + 
 
 4.7 (4.5-5.0) + 
 
       HDL cholesterol (mmol/l) 
        Pre 
       1.5 (1.4-1.5) 
 
 1.6 (1.4-1.7) 
       Post 
       1.5 
(1.4-1.6)NS 
 
 1.5 (1.4-1.6) 
+ 
 
       LDL cholesterol (mmol/l) 
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       Pre 
       3.1 (2.9-3.3)  3.1 (2.8-3.3) 
 
       Post 
       2.8 
(22.6-3.1) + 
 
 2.8 
(2.6-3.0) + 
 
       Triglycerides (mmol/l) 
       Pre 
       Pre 
1.2 (1.0-1.4) 
 
 
 Pre 
1.3 (1.1-1.4) 
 
 
 
       Post 
       1.0 (0.9-1.2) +  1.0 (0.8-1.2) 
+ 
 IER IER+PF CER IER IER+PF CER IER IER+PF CER 
Harvie et 
al.20 
(NR) 
   Waist circumference (cm) Glucose (mmol/l) 
 Pre Pre Pre 
 79.4 
(74.6-84.1) 
 
 
82.4 
(77.2-87.6) 
 
 
86.0 
(60.6-91.3) 
 
 
100.5 
(96.6-104.5) 
 
104.1 
(99.0-109.1) 
 
 
106.0 (101.9-
110.2) 
 
4.9 (4.7-5.0) 
 
5.0 (4.8-5.1) 
 
5.0 (4.8-5.1) 
 
 Post Post Post 
 73.9 
(69.4-78.5) 
77.3 
(72.5-82.1) 
82.2 
(76.9-87.5) 
94.4 
(90.5-98.3) 
98.8 
(94.1-103.6) 
102.4 
(98.0-106.8) 
4.8 (4.6-5.0) 
 
4.9 (4.7-5.1) 
 
4.9 (4.7-5.0) 
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    Fat mass (kg) Insulin (mmol/l) 
 
 
    Pre Pre 
    31.0 
(27.9-34.2) 
 
 
33.5 
(29.9-37.0) 
 
 
35.7 
(32.3-39.2) 
 
 
43.2 
(35.4-52.8) 
 
 
50.4 
(42.6-60.0) 
 
 
49.8 
(42.0-59.4) 
 
    Post Post 
    26.7 
(23.9-29.5) 
 
29.4 
(26.3-32.6) 
 
33.2 
(29.7-36.7) 
 
34.2 
(28.2-41.4) 
 
45.0 
(38.4-52.2) 
 
45.0 
(36.6-54.6) 
 
    Lean Mass (kg) Systolic blood pressure (mm/Hg) 
    Pre Pre 
    48.5 
(46.4-50.5) 
 
 
49.0 
(47.2-50.9) 
 
 
50.3 
(48.2-52.3) 
 
 
114.9 
(111.0-125.0) 
 
 
129.5 
(115.0-138.0) 
 
 
124.0 
(116.0-131.0) 
 
 
    Post Post 
    47.2 
(45.1-49.3) 
 
47.9 
(46.1-49.6) 
 
48.7 
(46.5-50.8) 
111.9 
(108.0-118.0) 
 
112.8 
(108.0-121.0) 
 
113.3 (107.0-
125.0) 
 
       Total cholesterol (mmol/l) 
       Pre 
       5.3 
(5.0-5.6) 
 
5.7 
(5.3-6.1) 
 
 
5.3 
(5.0-5.7) 
 
        Post 
       5.1 
(4.7-5.4) 
 
5.5 
(5.1-5.9) 
 
5.3 
(5.0-5.5) 
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       HDL cholesterol (mmol/l) 
       Pre 
       1.4 
(1.3-1.5) 
 
 
1.4 
(1.3-1.5) 
 
 
1.3 
(1.2-1.4) 
 
 
       Post 
       1.4 
(1.2-1.5) 
 
1.4 
(1.3-1.6) 
 
1.4 
(1.3-1.5) 
 
       LDL cholesterol (mmol/l) 
        
        
3.3 (3.0-3.6) 
 
Pre 
3.7 (3.4-4.1) 
 
 
 
3.4 (3.1-3.6) 
 
 
       Post 
       3.2 (2.9-3.5) 
 
3.6 (3.2-3.9) 
 
3.3 (3.1-3.5) 
 
       Triglycerides (mmol/l) 
       Pre 
       1.0 (0.9-1.2) 
 
 
1.1 (0.9-1.2) 
 
 
1.1 (0.9-1.3) 
 
       Post 
       0.9 (0.8-1.0) 0.9 (0.8-1.1) 
 
1.0 (0.9-1.2) 
Hill et al.21       Total cholesterol (mmol/l) 
       Pre 
JBI Database of Systematic Reviews & Implementation Reports 
Page 41 
Created by XMLmind XSL-FO Converter. 
 
(NR) 
-7.2 ± 2.7  -9.5 ± 2.9    5.5 ± 0.3 
 
 5.1 ± 0.2 
 
 
       Post 
       4.7 ± 0.2  4.8 ± 0.3 
Varady et 
al.26 
   Fat mass 
(kg) 
 
  Systolic blood pressure (mm/Hg) 
 -5.2 ± 0.9*   -3.6 ± 0.7NS   -7.0 ± 2.0+ 
 
 1.0 ± 3.0NS 
 
       Diastolic blood pressure (mm/Hg) 
       -6.0 ± 2.0+  2.0 ± 6.0 NS 
       Total cholesterol (mg/dl) 
       -26.0 ± 6.0+  -9.0 ± 5.0 NS 
       HDL cholesterol (mg/dl) 
       -2.0 ± 3.0NS  1.0 ± 2.0 NS 
       LDL cholesterol (mg/dl) 
       -18.0 ± 6.0+  -9.0 ± 4.0 NS 
       Triglycerides (mg/dl) 
       -22.0 ± 11.0NS  10.0 ± 7.0 NS 
Viegener 
et al.25 
-9.0 (6.7)  -9.0 (7.3)       
 1 
Results are presented for within group changes. Values represent mean ± SEM; mean (SD) 2 
NR: Within group statistics not reported (Harvie et al.20; Hill et al.21) 3 
Varady et al.26 Between group differences for weight and fat mass 4 
*Significance at p = <0.001 +Significance at p = <0.05 NS Not significant p = > 0.05  5 
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Table 4: Pooled effect sizes (Weighted Mean Difference) of secondary outcomes. 1 
    Heterogeneity 
Outcomes K Pooled estimate 
(95% CI) 
p-value Q 
(p-value) 
I2 T2 
IER vs CER       
Waist circumference 
(cm) 
2 -2.14 (-3.53 to -0.75) 0.002 0.01 
(0.938) 
0.0% 0.00 
Fat mass (kg) 2 -1.38 (-2.47 to -0.28) 0.014 0.49 
(0.483) 
0.0% 0.00 
Fat free mass (kg) 2 -0.02 (-0.80 to 0.76) 0.958 1.90 
(0.168) 
47.5% 0.15 
Glucose (mmol/l) 2 0.00 (-0.05 to 0.05) 1.000 0.00 
(1.000) 
0.0% 0.00 
Insulin (pmol/l) 2 -4.66 (-9.12 to -0.19) 0.041 2.57 
(0.109) 
61.1% 6.36 
Total cholesterol 
(mmol/l) 
3 -0.14 (-0.50 to 0.23) 0.458 27.33 
(<0.001) 
92.7% 0.10 
LDL cholesterol 
(mmol/l) 
2 -0.05 (-0.15 to 0.05) 0.343 1.08 
(0.298) 
7.7% 0.00 
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HDL cholesterol 
(mmol/l) 
2 0.03 (-0.10 to 0.16) 0.645 6.59 
(0.010) 
84.8% 0.01 
Triglyceride (mmol/l) 2 -0.03 (-0.10 to 0.03) 0.314 0.690 
(0.406) 
0.0% 0.00 
IER vs Control       
Fat mass (kg) 2 -3.24 (-4.55 to -1.92) <0.001 1.12 
(0.290) 
10.7% 0.14 
Systolic BP (mmHg) 2 -4.29 (-11.13 to 2.56) 0.220 2.13 
(0.144) 
53.1% 13.00 
Diastolic BP (mmHg) 2 -3.81 (-11.64 to 4.02) 0.340 2.78 
(0.095) 
64.1% 20.50 
IER = Intermittent energy restriction; CER = Continuous energy restriction; K = number of studies; CI = 1 
confidence interval; Q = heterogeneity statistic for the model; I2 = index of heterogeneity beyond within-2 
study sampling error; T2 = estimate of the between-study variance; LDL = Low density lipoprotein; HDL 3 
= High density lipoprotein. 4 
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Appendix I: Search strategy 9 
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily, Ovid 10 
MEDLINE(R) and Ovid OLDMEDLINE(R) <1946 to 2015 November 21> 11 
Search Strategy: 12 
-------------------------------------------------------------------------------- 13 
1     exp Obesity/  14 
2     obes*.tw.  15 
3     body mass.tw.  16 
4     exp Body Composition/  17 
5     body composition.tw.  18 
6     exp Body Size/  19 
7     body siz*.tw.  20 
8     bodysiz*.tw.  21 
9     exp Body Weight/  22 
10     body weight.tw.  23 
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11     fat.tw.  1 
12     fatness.tw.  2 
13     exp Overnutrition/  3 
14     overnutrition.tw.  4 
15     exp Overweight/  5 
16     overweight.tw.  6 
17     over weight.tw.  7 
18     weight.tw.  8 
19     exp Weight Gain/  9 
20     weight gain.tw.  10 
21     weight maintenance.tw.  11 
22     weight management.tw.  12 
23     1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 13 
or 20 or 21 or 22  14 
24     exp Fasting/  15 
25     intermittent fast*.tw.  16 
26     alternate-day fast*.tw.  17 
27     intermittent energy restriction*.tw.  18 
28     intermittent calori* restriction*.tw.  19 
29     intermittent restrictive diet*.tw.  20 
30     continuous energy restriction*.tw.  21 
31     continuous calori* restriction*.tw.  22 
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32     continuous restrictive diet*.tw.  1 
33     fasting calorie restriction intervention*.tw.  2 
34     very low calorie diet*.tw.  3 
35     periodic fasting*.tw.  4 
36     extreme diet*.tw.  5 
37     800* kcal.tw.  6 
38     500 calorie*.tw.  7 
39     sporadic fast*.tw.  8 
40     24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39  9 
41     23 and 40 10 
42     exp Adiposity/  11 
43     exp Adipose Tissue/  12 
44     (adverse adj (event* or inciden*)).tw.  13 
45     bio-impedance.tw.  14 
46     bioimpedance.tw.  15 
47     bioelectrical impedance analysis.tw.  16 
48     exp Blood Glucose/  17 
49     blood glucose.tw.  18 
50     exp Blood Pressure/  19 
51     blood pressure*.tw.  20 
52     exp Body Mass Index/  21 
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53     body mass index.tw.  1 
54     BMI.tw.  2 
55     bodpod.tw.  3 
56     exp Cholesterol/  4 
57     cholesterol.tw.  5 
58     exp Diet/  6 
59     diet.tw.  7 
60     exp Absorptiometry, Photon/  8 
61     dexa scan*.tw.  9 
62     dxa.tw.  10 
63     exp Exercise/  11 
64     exercise.tw.  12 
65     hydrostatic.tw.  13 
66     exp Magnetic Resonance Imaging/  14 
67     magnetic resonance imag*.tw.  15 
68     MRI.tw.  16 
69     exp Skinfold Thickness/  17 
70     skin-fold.tw.  18 
71     exp Waist Circumference/  19 
72     waist circumference.tw.  20 
73     exp Weight Loss/  21 
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74     weight loss.tw.  1 
75     slim.tw.  2 
76     slimming.tw.  3 
77     thin.tw.  4 
78     thinness.tw.  5 
79     42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 6 
or 59 or 60 or 61 or 62 or 63 or 64 or 65 or 66 or 67 or 68 or 69 or 70 or 71 or 72 or 73 or 74 or 75 or 7 
76 or 77 or 78  8 
80     23 and 40 and 79  9 
81     limit 80 to english language  10 
82     80 not 81  11 
83     exp Randomized Controlled Trials as Topic/  12 
84     exp Randomized Controlled Trial/  13 
85     exp Random Allocation/  14 
86     exp Double-Blind Method/  15 
87     exp Single-Blind Method/  16 
88     exp Clinical Trial/  17 
89     clinical trial, phase i.pt.  18 
90     clinical trial, phase ii.pt.  19 
91     clinical trial, phase iii.pt.  20 
92     clinical trial, phase iv.pt.  21 
93     controlled clinical trial.pt.  22 
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94     randomized controlled trial.pt.  1 
95     multicenter study.pt.  2 
96     clinical trial.pt.  3 
97     exp Clinical Trials as topic/  4 
98     or/83-97  5 
99     (clinical adj trial*).tw.  6 
100     ((singl* or doubl* or treb* or tripl*) adj (blind* or mask*)).tw.  7 
101     exp Placebos/  8 
102     placebo$.tw.  9 
103     randomly allocated.tw.  10 
104     (allocated adj2 random$).tw.  11 
105     or/99-104  12 
106     98 or 105  13 
107     case report.tw.  14 
108     letter/  15 
109     historical article/  16 
110     or/107-109  17 
111     106 not 110  18 
112     81 and 111 19 
  20 
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Database: Embase <1974 to 2016 January 08> 1 
Search Strategy: 2 
-------------------------------------------------------------------------------- 3 
1     exp obesity/  4 
2     obes*.tw.  5 
3     exp body mass/  6 
4     body mass.tw.  7 
5     exp body composition/  8 
6     body composition.tw.  9 
7     exp body size/  10 
8     body siz*.tw.  11 
9     bodysiz*.tw.  12 
10     exp body weight/  13 
11     body weight.tw.  14 
12     exp fat body/  15 
13     fat.tw.  16 
14     fatness.tw.  17 
15     exp overnutrition/  18 
16     overnutrition.tw.  19 
17     overweight.tw.  20 
18     over weight.tw.  21 
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19     weight.tw.  1 
20     exp weight gain/  2 
21     weight gain.tw.  3 
22     weight maintenance.tw.  4 
23     weight management.tw.  5 
24     1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 6 
or 20 or 21 or 22 or 23  7 
25     exp diet restriction/  8 
26     fasting.tw.  9 
27     intermittent fast*.tw.  10 
28     alternate-day fast*.tw.  11 
29     exp caloric restriction/  12 
30     intermittent energy restriction*.tw.  13 
31     intermittent calori* restriction*.tw.  14 
32     intermittent restrictive diet*.tw.  15 
33     continuous energy restriction*.tw.  16 
34     continuous calori* restriction*.tw.  17 
35     continuous restrictive diet*.tw.  18 
36     fasting calorie restriction intervention*.tw.  19 
37     very low calorie diet*.tw.  20 
38     periodic fasting*.tw.  21 
39     extreme diet*.tw.  22 
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40     800* kcal.tw.  1 
41     500 calorie*.tw.  2 
42     sporadic fast*.tw.  3 
43     25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 4 
or 42  5 
44     24 and 43  6 
45     adiposity.tw.  7 
46     exp adipose tissue/  8 
47     (adverse adj (event* or inciden*)).tw.  9 
48     bio-impedance.tw.  10 
49     bioimpedance.tw.  11 
50     bioelectrical impedance analysis.tw.  12 
51     exp glucose blood level/  13 
52     blood glucose.tw.  14 
53     exp blood pressure/  15 
54     blood pressure*.tw.  16 
55     body mass index.tw.  17 
56     BMI.tw.  18 
57     bodpod.tw.  19 
58     exp cholesterol/  20 
59     cholesterol.tw.  21 
60     exp diet/  22 
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61     diet.tw.  1 
62     exp photon absorptiometry/  2 
63     exp dual energy X ray absorptiometry/  3 
64     dexa scan*.tw.  4 
65     dxa.tw.  5 
66     exp exercise/  6 
67     exercise.tw.  7 
68     hydrostatic.tw.  8 
69     exp nuclear magnetic resonance imaging/  9 
70     magnetic resonance imag*.tw.  10 
71     MRI.tw.  11 
72     exp skinfold thickness/  12 
73     skin-fold.tw.  13 
74     exp waist circumference/  14 
75     waist circumference.tw.  15 
76     exp weight reduction/  16 
77     weight loss.tw.  17 
78     slim.tw.  18 
79     slimming.tw.  19 
80     thin.tw.  20 
81     thinness.tw.  21 
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82     45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 1 
or 62 or 63 or 64 or 65 or 66 or 67 or 68 or 69 or 70 or 71 or 72 or 73 or 74 or 75 or 76 or 77 or 78 or 2 
79 or 80 or 81  3 
83     24 and 43 and 82  4 
84     limit 83 to english  5 
85     83 not 84  6 
86     limit 83 to (conference abstract or conference paper or conference proceeding or "conference 7 
review")  8 
87     83 not 86  9 
88     clinical trial/  10 
89     randomized controlled trial/  11 
90     exp randomization/  12 
91     single blind procedure/  13 
92     double blind procedure/  14 
93     crossover procedure/  15 
94     exp placebo/  16 
95     randomi?ed controlled trial*.tw.  17 
96     RCT.tw.  18 
97     random allocation.tw.  19 
98     randomly allocated.tw.  20 
99     allocated randomly.tw.  21 
100     (allocated adj2 random).tw.  22 
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101     single blind*.tw.  1 
102     double blind*.tw.  2 
103     (treble adj blind*).tw.  3 
104     (triple adj blind*).tw.  4 
105     placebo*.tw.  5 
106     exp prospective study/  6 
107     or/88-106  7 
108     exp case study/  8 
109     case report.tw.  9 
110     abstract report/ or letter/  10 
111     or/108-110  11 
112     107 not 111  12 
113     87 and 112 13 
  14 
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Database: CINAHL (Cumulative Index of Nursing and Allied Health Literature <1981 to 2015 November 1 
21> 2 
Search Strategy: 3 
S1 (MH "Obesity+")  4 
S2 TI obes* OR AB obes*  5 
S3 TI body mass OR AB body mass  6 
S4 (MH "Body Composition+")  7 
S5 TI body composition OR AB body composition  8 
S6 (MH "Body Size")  9 
S7 TI body siz* OR AB body siz*  10 
S8 TI bodysiz* OR AB bodysiz*  11 
S9 (MH "Body Weight+")  12 
S10 TI body weight OR AB body weight  13 
S11 TI fat OR AB fat  14 
S12 TI fatness OR AB fatness  15 
S13 TI overnutrition OR AB overnutrition  16 
S14  TI overweight OR AB overweight  17 
S15 TI over weight OR AB over weight  18 
S16 TI weight OR AB weight  19 
S17 (MH "Weight Gain+")  20 
S18 TI weight gain OR AB weight gain  21 
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S19 (MH "Weight Control")  1 
S20 TI weight maintenance OR AB weight maintenance  2 
S21 TI weight management OR AB weight management  3 
S22 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR 4 
S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21  5 
S23 (MH "Fasting")  6 
S24 TI intermittent fast* OR AB intermittent fast*  7 
S25 TI alternate-day fast* OR AB alternate-day fast*  8 
S26 (MH "Restricted Diet+")  9 
S27 TI intermittent energy restriction* OR AB intermittent energy restriction*  10 
S28 TI intermittent calori* restriction* OR AB intermittent calori* restriction*  11 
S29 TI intermittent restrictive diet* OR AB intermittent restrictive diet*  12 
S30 TI continuous energy restriction* OR AB continuous energy restriction*  13 
S31 TI continuous calori* restriction* OR AB continuous calori* restriction*  14 
S32 TI continuous restrictive diet* OR AB continuous restrictive diet*  15 
S33 TI fasting calorie restriction intervention* OR AB fasting calorie restriction intervention*  16 
S34 TI very low calorie diet* OR AB very low calorie diet*  17 
S35 TI periodic fasting* OR AB periodic fasting*  18 
S36 TI extreme diet* OR AB extreme diet*  19 
S37 TI 800* kcal OR AB 800* kcal  20 
S38 TI 500 calorie* OR AB 500 calorie*  21 
S39 TI sporadic fast* OR AB sporadic fast*  22 
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S40 S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR 1 
S34 OR S35 OR S36 OR S37 OR S38 OR S39 2 
S41 S22 AND S40  3 
S42 TI adiposity OR AB adiposity  4 
S43 (MH "Adipose Tissue+")  5 
S44 TI "adverse event*" OR AB "adverse event*"  6 
S45 TI "adverse inciden*" OR AB "adverse inciden*"  7 
S46 TI bio-impedance OR AB bio-impedance  8 
S47 TI bioimpedance OR AB bioimpedance  9 
S48 TI bioelectrical impedance analysis OR AB bioelectrical impedance analysis  10 
S49 (MH "Blood Glucose")  11 
S50 TI blood glucose OR AB blood glucose  12 
S51 (MH "Blood Pressure+")  13 
S52 TI blood pressure* OR AB blood pressure*  14 
S53 (MH "Body Mass Index")  15 
S54 TI "body mass index" OR AB "body mass index"  16 
S55 TI BMI OR AB BMI  17 
S56 TI bodpod OR AB bodpod  18 
S57 (MH "Cholesterol+")  19 
S58 TI cholesterol OR AB cholesterol  20 
S59 (MH "Diet+")  21 
S60 TI diet OR AB diet  22 
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S61 (MH "Absorptiometry, Photon")  1 
S62 TI dexa scan* OR AB dexa scan*  2 
S63 TI dxa OR AB dxa  3 
S64 (MH "Exercise+")  4 
S65 TI exercise OR AB exercise  5 
S66 TI hydrostatic OR AB hydrostatic  6 
S67 (MH "Magnetic Resonance Imaging+")  7 
S68 TI magnetic resonance imag* OR AB magnetic resonance imag*  8 
S69 TI MRI OR AB MRI  9 
S70 (MH "Skinfold Thickness")  10 
S71 TI skin-fold OR AB skin-fold  11 
S72 (MH "Waist Circumference")  12 
S73 TI waist circumference OR AB waist circumference  13 
S74 (MH "Weight Loss+")  14 
S75 TI weight loss OR AB weight loss  15 
S76 TI slim OR AB slim  16 
S77 TI slimming OR AB slimming  17 
S78 TI thin OR AB thin  18 
S79 TI thinness OR AB thinness  19 
S80 S42 OR S43 OR S44 OR S45 OR S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR 20 
S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60 OR S61 OR S62 OR S63 OR S64 21 
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OR S65 OR S66 OR S67 OR S68 OR S69 OR S70 OR S71 OR S72 OR S73 OR S74 OR S75 OR S76 1 
OR S77 OR S78 OR S79  2 
S81 S22 AND S40 AND S80 3 
  4 
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Database: Cochrane Library 1 
Date Run: 21/11/15 17:51:35.234 2 
Description:   3 
 4 
ID Search Hits 5 
#1 MeSH descriptor: [Obesity] explode all trees 6 
#2 obes*:ti,ab  7 
#3 body mass:ti,ab  8 
#4 MeSH descriptor: [Body Composition] explode all trees  9 
#5 body composition:ti,ab   10 
#6 MeSH descriptor: [Body Size] explode all trees  11 
#7 body siz*:ti,ab   12 
#8 bodysiz*:ti,ab   13 
#9 MeSH descriptor: [Body Weight] explode all trees  14 
#10 body weight:ti,ab   15 
#11 fat:ti,ab  16 
#12 fatness:ti,ab   17 
#13 MeSH descriptor: [Overnutrition] explode all trees  18 
#14 overnutrition:ti,ab   19 
#15 MeSH descriptor: [Overweight] explode all trees  20 
#16 overweight:ti,ab   21 
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#17 over weight:ti,ab   1 
#18 weight:ti,ab   2 
#19 MeSH descriptor: [Weight Gain] explode all trees  3 
#20 weight gain:ti,ab   4 
#21 weight maintenance:ti,ab   5 
#22 weight management:ti,ab   6 
#23 {or #1-#22}   7 
#24 MeSH descriptor: [Fasting] explode all trees  8 
#25 intermittent fast*:ti,ab   9 
#26 alternate-day fast*:ti,ab   10 
#27 intermittent energy restriction*:ti,ab   11 
#28 intermittent calori* restriction*:ti,ab   12 
#29 intermittent restrictive diet*:ti,ab   13 
#30 continuous energy restriction*:ti,ab   14 
#31 continuous calori* restriction*:ti,ab   15 
#32 continuous restrictive diet*:ti,ab   16 
#33 fasting calorie restriction intervention*:ti,ab   17 
#34 very low calorie diet*:ti,ab   18 
#35 periodic fasting*:ti,ab   19 
#36 extreme diet*:ti,ab   20 
#37 800* kcal:ti,ab   21 
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#38 500 calorie*:ti,ab   1 
#39 sporadic fast*:ti,ab   2 
#40 {or #24-#39}   3 
#41 #23 and #40   4 
#42 MeSH descriptor: [Adiposity] explode all trees  5 
#43 MeSH descriptor: [Adipose Tissue] explode all trees  6 
#44 adverse event*:ti,ab   7 
#45 adverse inciden*:ti,ab   8 
#46 bio-impedance:ti,ab   9 
#47 bioimpedance:ti,ab   10 
#48 bioelectrical impedance analysis:ti,ab   11 
#49 MeSH descriptor: [Blood Glucose] explode all trees  12 
#50 blood glucose:ti,ab   13 
#51 MeSH descriptor: [Blood Pressure] explode all trees  14 
#52 blood pressure*:ti,ab   15 
#53 MeSH descriptor: [Body Mass Index] explode all trees  16 
#54 body mass index:ti,ab   17 
#55 BMI:ti,ab   18 
#56 bodpod:ti,ab   19 
#57 MeSH descriptor: [Cholesterol] explode all trees  20 
#58 cholesterol:ti,ab   21 
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#59 MeSH descriptor: [Diet] explode all trees  1 
#60 diet:ti,ab   2 
#61 MeSH descriptor: [Absorptiometry, Photon] explode all trees  3 
#62 dexa scan*:ti,ab   4 
#63 dxa:ti,ab   5 
#64 MeSH descriptor: [Exercise] explode all trees  6 
#65 exercise:ti,ab   7 
#66 hydrostatic:ti,ab   8 
#67 MeSH descriptor: [Magnetic Resonance Imaging] explode all trees  9 
#68 magnetic resonance imag*:ti,ab   10 
#69 MRI:ti,ab   11 
#70 MeSH descriptor: [Skinfold Thickness] explode all trees  12 
#71 skin-fold:ti,ab   13 
#72 MeSH descriptor: [Waist Circumference] explode all trees  14 
#73 waist circumference:ti,ab   15 
#74 MeSH descriptor: [Weight Loss] explode all trees  16 
#75 weight loss:ti,ab   17 
#76 slim:ti,ab   18 
#77 slimming:ti,ab   19 
#78 thin:ti,ab   20 
#79 thinness:ti,ab   21 
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#80 {or #42-#79}   1 
#81 #23 and #40 and #80  2 
 3 
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Appendix II: Appraisal instruments 1 
MAStARI appraisal instrument 2 
 3 
 4 
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 1 
 2 
 3 
Appendix III: Data extraction instruments 4 
MAStARI data extraction instrument 5 
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Appendix IV: GRADE Assessments 1 
Question: Intermittent energy restriction compared to usual care for treatment for overweight and obesity in adult population   2 
Quality assessment 
№ of patients Effect 
Quality Importance 
№ of 
studies 
Study 
design 
Risk of bias Inconsistency Indirectness Imprecision Other considerations 
intermittent 
energy restriction 
usual care 
Absolute 
(95% CI) 
Weight (kg) 
4  randomised 
trials  
serious a not serious  serious b serious c all plausible residual 
confounding would reduce 
the demonstrated effect 
dose response gradient  
161  126  MD 1.03 lower 
(2.46 lower to 0.1 higher) 
⨁⨁⨁◯ 
MODERATE  
IMPORTANT  
CI: Confidence interval; MD: Mean difference 3 
a. Two out of the four included studies present high risk of bias for: performance, detection and attrition  4 
b. There was a serious risk of indirectness due to the limited age range of participants and heterogeneous gender distribution.  5 
 6 
c. There was serious imprecision considering the small number of studies and events and wide confidence interval.  7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
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 1 
Question: Intermittent energy restriction compared to no treatment control for treatment overweight or obesity in adults   2 
Quality assessment 
№ of patients Effect 
Quality Importance 
№ of 
studies 
Study 
design 
Risk of bias Inconsistency Indirectness Imprecision Other considerations 
intermittent 
energy restriction  
no treatment 
Absolute 
(95% CI) 
Weight (kg) 
2  randomised 
trials  
serious a very serious b serious c serious d strong association 
all plausible residual 
confounding would reduce 
the demonstrated effect 
dose response gradient  
31  31  -  
MD 4.22 mean difference lower 
(5.48 lower to 2.97 lower)  
⨁⨁◯◯ 
LOW  
IMPORTANT  
CI: Confidence interval; MD: Mean difference 3 
a. There was high risks of bias including: performance and detection bias  4 
b. There was serious inconsistency with high and significant heterogeneity  5 
c. There was a serious risk of indirectness due to the limited age range of participants and heterogeneous gender distribution  6 
d. There was serious imprecision considering the small number of studies and events and wide confidence interval.  7 
 8 
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Appendix V: Excluded studies 
Reason for exclusion: Not a randomised control trial study design (n = 10) 
1. Anderlova K, Kremen J, Dolezalova R, Housovaj J. The influence of very-low-calorie diet on 
serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women. Physiol 
Res. 2006; 55(3):277. 
 
2. Bailey BW, Jacobsen DJ, Donnelly JE. Weight loss and maintenance outcomes using 
moderate and severe caloric restriction in an outpatient setting. Dis Manag. 2008; 11(3):176-
80. 
 
3. Garfield G, Duncan MD. Intermittent fasts in the correction and control of intractable obesity. 
Trans Am Clin Climatol Assoc. 1963; 74:121. 
 
4. Gillen JB, Percival ME, Ludzki A, Tarnopolsky MA, Gibala M. Interval training in the fed or 
fasted state improves body composition and muscle oxidative capacity in overweight women. 
Obes. 2013; 21(11):2249-55. 
 
5. Hoddy KK, Kroeger CM, Trepanowski JF, Barnosky AR, Bhutani S, Varady KA. Safety of 
alternate day fasting and effect on disordered eating behaviors. Nutr J. 2015; 14(1):1. 
 
6. Johnson JB, Laub DR, John S. The effect on health of alternate day calorie restriction: eating 
less and more than needed on alternate days prolongs life. Med Hypotheses. 2006; 
67(2):209-11. 
 
7. Joseph LJ, Prigeon RL, Blumenthal JB, Ryan AS, Goldberg AP. Weight loss and low-intensity 
exercise for the treatment of metabolic syndrome in obese postmenopausal women. The 
Journals of Gerontology Series A: Bio Sci Med Sci. 2011; 66(9):1022-9. 
 
8. Klempel MC, Bhutani S, Fitzgibbon M, Freels S, Varady KA. Dietary and physical activity 
adaptations to alternate day modified fasting: implications for optimal weight loss. Nutr J. 
2010; 9(1):1. 
 
9. Stewart WK, Fleming LW, Robertson PC. Massive obesity treated by intermittent fasting: A 
metabolic and clinical study. Am J Med. 1966;40(6):967-86. 
 
10. Wright G, Dawson B, Jalleh G, Couch MH. A retrospective comparison of two very low energy 
diets on weight loss and health status in obese women completing a 26-week program. Obes 
Res Clin Pract. 2007; 1(4):281-8. 
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Reason for exclusion: Not published in English language (n = 2) 
11. Jing RY, Bian HW. Evaluation of the Effectiveness of Losing Weight and Keeping Fit by 
Controlling Diet and Having Appropriate Physical Activities. Chinese J Clin Nutr. 2006; 3:009. 
 
12. Martinez-Riquelme A, Sajoux I, Fondevila J. [Results of PROMESA I study; efficacy and 
safety of a very low calorie diet application and following alimentary reeducation with the 
PronoKal® method in the treatment of excess of weight]. Nutr Hosp. 2013; 29(2):282-91. 
Reason for exclusion: IER intervention less than 12 weeks duration (n = 5) 
 
13. Arguin H, Dionne IJ, Sénéchal M, Bouchard DR, Carpentier AC, Ardilouze JL, et al. Short-and 
long-term effects of continuous versus intermittent restrictive diet approaches on body 
composition and the metabolic profile in overweight and obese postmenopausal women: a 
pilot study. Menopause. 2012; 19(8):870-6. 
 
14. Eshghinia S, Mohammadzadeh F. The effects of modified alternate-day fasting diet on weight 
loss and CAD risk factors in overweight and obese women. J Diabetes Metab Disord. 2013; 
12(1):1. 
 
15. Klempel MC, Kroeger CM, Varady KA. Alternate day fasting increases LDL particle size 
independently of dietary fat content in obese humans. Eur J Clin Nutr. 2013; 67(7):783-5. 
 
16. Klempel MC, Kroeger CM, Varady KA. Alternate day fasting (ADF) with a high-fat diet 
produces similar weight loss and cardio-protection as ADF with a low-fat diet. Metab. 2013; 
62(1):137-43. 
 
17. Wright JL, Plymate S, D'Oria‐Cameron A, Bain C, Haugk K, Xiao L, et al. A study of caloric 
restriction versus standard diet in overweight men with newly diagnosed prostate cancer: a 
randomized controlled trial. Prostate. 2013; 73(12):1345-51. 
Reason for exclusion: Not original article, review article (n = 11) 
 
18. Boling CL, Westman EC, Yancy WS. Comparison of weight loss diets. N Engl J Med. 2009. 
26; 360(9): 2247-2248. 
 
19. Brown JE, Mosley M, Aldred S. Intermittent fasting: a dietary intervention for prevention of 
diabetes and cardiovascular disease? Brit J Diab Vasc Dis. 2013 Mar 1;13(2):68-72. 
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20. Carpentier AC. Acute Adaptation of Energy Expenditure Predicts Diet-Induced Weight Loss: 
Revisiting the Thrifty Phenotype. Diabetes. 2015; 64(8):2714-6. 
 
21. Champ CE, Simone NL. RE: Calorie or carbohydrate restriction? The ketogenic diet as 
another option for supportive cancer treatment. Oncologist.2013; 18; 1057. 
 
22. Farsad Naimi A, Nourmohammady M. Effect of Moderate-carbohydrate and Low-calorie Diet 
on Metabolic Risk Factors, Liver Enzymes and Sonographic Findings in Patients with Non-
alcoholic Fatty Liver Disease (NAFLD). Iranian J Endocrinol Metab. 2013; 15(3):262-8. 
 
23. Horne BD, Muhlestein JB, Anderson JL. Health effects of intermittent fasting: hormesis or 
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